Repository logo
  • Log In
    New user? Click here to register.Have you forgotten your password?
University College Dublin
  • Colleges & Schools
  • Statistics
  • All of DSpace
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Health and Agricultural Sciences
  3. School of Nursing, Midwifery & Health Systems
  4. Nursing, Midwifery & Health Systems Research Collection
  5. The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin and non-Hodgkin lymphomas: A scoping review
 
  • Details
Options

The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin and non-Hodgkin lymphomas: A scoping review

File(s)
FileDescriptionSizeFormat
Download The_assessment_and_management_of_chemotherapy-related_toxicities_in_patients_with_breast_cancer,_colorectal_cancer,_and_Hodgkin_and_non-Hodgkin_lymphomas,_a_scoping_review.docx208.67 KB
Author(s)
Fox, Patricia A. 
Darley, Andrew 
Furlong, Eileen 
et al. 
Uri
http://hdl.handle.net/10197/8347
Date Issued
February 2017
Date Available
01T02:00:14Z February 2018
Abstract
Purpose: The purpose of the eSMART (Electronic Symptom Management using the Advanced Symptom Management System (ASyMS) Remote Technology) study is to evaluate the use of mobile phone technology to manage chemotherapy-related toxicities (CRTs) in people with breast cancer (BC), colorectal cancer (CRC), Hodgkin's lymphoma (HL), and non-Hodgkin lymphoma (NHL)) across multiple European sites. One key objective was to review the published and grey literature on assessment and management of CRTs among patients receiving primary chemotherapy for BC, CRC, HL, and NHL to ensure that ASyMS remained evidence-based and reflected current and local practice. Methods: Three electronic databases were searched for English papers, with abstracts available from 01/01/2004-05/04/2014. For the grey literature, relevant clinical practice guidelines (CPGs)/evidence-based resources (EBRs) from the main international cancer organisations were reviewed as were symptom management (SM) protocols from the sites. Results: After full-text screening, 27 publications were included. The majority (n = 14) addressed fatigue and focused on BC patients. Relevant CPGs/EBRs were found for fatigue (n = 4), nausea/vomiting (n = 5), mucositis (n = 4), peripheral neuropathy (n = 3), diarrhoea (n = 2), constipation (n = 2), febrile neutropenia/infection (n = 7), palmar plantar erythrodysesthesia (PPE) (n = 1), and pain (n = 4). SM protocols were provided by >40% of the clinical sites. Conclusions: A need exists for empirical research on SM for PPE, diarrhoea, and constipation. Research is needed on the efficacy of self-care strategies in patients with BC, CRC, HL, and NHL. In general, consistency exists across CPGs/EBRs and local guidelines on the assessment and management of common CRTs.
Type of Material
Journal Article
Publisher
Elsevier
Journal
European Journal of Oncology Nursing
Volume
26
Start Page
63
End Page
82
Copyright (Published Version)
2016 Elsevier
Keywords
  • Assessment

  • Management

  • Chemotherapy

  • Toxicity

  • Symptom

  • Scoping review

  • Clinical practice gui...

DOI
10.1016/j.ejon.2016.12.008
Language
English
Status of Item
Peer reviewed
This item is made available under a Creative Commons License
https://creativecommons.org/licenses/by-nc-nd/3.0/ie/
Owning collection
Nursing, Midwifery & Health Systems Research Collection
Scopus© citations
18
Acquisition Date
Mar 22, 2023
View Details
Views
1589
Acquisition Date
Mar 22, 2023
View Details
Downloads
180
Last Week
3
Last Month
4
Acquisition Date
Mar 22, 2023
View Details
google-scholar
University College Dublin Research Repository UCD
The Library, University College Dublin, Belfield, Dublin 4
Phone: +353 (0)1 716 7583
Fax: +353 (0)1 283 7667
Email: mailto:research.repository@ucd.ie
Guide: http://libguides.ucd.ie/rru

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement